Learn More

Confidence in COVID-19 testing results helps free us all to focus on the great things in life. PCR-based tests are designed to enable early virus detection, even in asymptomatic cases, and help deliver reliable answers.

Clearly, at this critical time, product safety and HACCP are as important as they have ever been, and in the current pandemic, food and beverage companies, retailers, public health authorities and other businesses are seeking solutions to monitor the presence of SARS-CoV-2 in their environments.

Features of the TaqPath COVID-19 Fast PCR Combo Kit 2.0: Fast, direct-to-PCR workflow from raw saliva Simple and affordable Gold standard technology Innovative, multi-target design, The TaqPath COVID-19 Fast PCR Combo Kit 2.0 workflow does not require RNA extraction and provides results in ~2 hours.

Human sample confirmation Innovative, multi-target assay design Sensitive detection for symptomatic or asymptomatic cases Affordable and scalable, The TaqPath COVID-19 RNase P Combo Kit 2.0 utilizes a standard workflow that provides results in ~3 hours.

In response to the novel coronavirus (SARS-CoV-2) outbreak, Thermo Fisher Scientific has worked rapidly to develop a multiplex real-time PCR diagnostic kit to enable clinical and public health laboratories to quickly diagnose COVID-19 caused by SARS-CoV-2 infection.

We are expanding global testing solutions and urgently working on innovative ideas to meet the evolving needs of today and tomorrow so the world can keep moving., We are a trusted partner during this time, enabling unprecedented testing demand and providing accurate, proven results.

Viruses constantly mutate, leading to the emergence of new variants. SARS-CoV-2 is no exception. Multiple variants of SARS-CoV-2, such as Alpha, Delta, and Omicron, have appeared globally in this pandemic.

In order to provide increased confidence in our COVID-19 test results as SARS-CoV-2 continues to mutate, our TaqPath COVID-19 2.0 tests employ an advanced assay design with increased target redundancy to compensate for both currently known and future SARS-CoV-2 mutations.

The arrival of COVID-19 into the ecosystem changed the way we approach respiratory testing. Gone are the days of relying on a rapid test to diagnose an infection. PCR or molecular testing is now the gold standard.

Prompt and early diagnosis of respiratory pathogens that cause severe illness is criticalto help inform patient management, treatment decisions, and preventing the spread of disease. Confidence in testing results allows clinicians and patients to make informed decisions—including seeking medical...

Thermo Fisher Scientific is the leading single-source supplier for COVID-19-related testing needs, with involvement in more than 50% of worldwide testing. We have the instruments, test kits, and reagents the world needs now, and we’ve accelerated our development pipeline to provide new, innovative...

In this study, two RT-PCR diagnostic tests were analyzed using Next Generation Sequencing (NGS) to determine accuracy. Download now›, Read about the comparison ofclinicalperformance oftwoEUA-approved RT-PCR diagnostic testsin nasal swabs.

The Thermo Fisher Scientific Amplitude Solution version 2.0 is an automated molecular diagnostic testing system that provides an improved streamlined workflow, uses minimal resources, and offers high throughput options, to maximize lab efficiency.

Get fast and highly reliable insight into the safety of indoor air for risk mitigation. Help protect employees and communities with confidence, while maintaining business and operational continuity. Next-level confidence, safety, and reliability. Contact us Join our community, Need further support?

Watch these on-demand webinars to learn why Thermo Fisher Scientific is the leading single-source supplier for your COVID-19 testing needs., Throughout the current global crisis, SARS-CoV-2 has continued to mutate.